- Home
- QURE vs IRMD Comparison
QURE vs IRMD Comparison
Compare QURE & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- IRMD
- Stock Information
- Founded
- QURE 1998
- IRMD 1992
- Country
- QURE Netherlands
- IRMD United States
- Employees
- QURE N/A
- IRMD N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- IRMD Medical/Dental Instruments
- Sector
- QURE Health Care
- IRMD Health Care
- Exchange
- QURE Nasdaq
- IRMD Nasdaq
- Market Cap
- QURE 860.8M
- IRMD 749.9M
- IPO Year
- QURE 2007
- IRMD 2014
- Fundamental
- Price
- QURE $15.18
- IRMD $59.81
- Analyst Decision
- QURE Strong Buy
- IRMD Strong Buy
- Analyst Count
- QURE 8
- IRMD 1
- Target Price
- QURE $33.00
- IRMD $60.00
- AVG Volume (30 Days)
- QURE 1.2M
- IRMD 38.6K
- Earning Date
- QURE 02-26-2025
- IRMD 02-06-2025
- Dividend Yield
- QURE N/A
- IRMD 1.00%
- EPS Growth
- QURE N/A
- IRMD 13.16
- EPS
- QURE N/A
- IRMD 1.46
- Revenue
- QURE $28,587,000.00
- IRMD $71,305,130.00
- Revenue This Year
- QURE $153.92
- IRMD $13.29
- Revenue Next Year
- QURE N/A
- IRMD $10.76
- P/E Ratio
- QURE N/A
- IRMD $41.27
- Revenue Growth
- QURE N/A
- IRMD 13.23
- 52 Week Low
- QURE $3.73
- IRMD $40.18
- 52 Week High
- QURE $19.18
- IRMD $61.00
- Technical
- Relative Strength Index (RSI)
- QURE 52.73
- IRMD 71.20
- Support Level
- QURE $13.70
- IRMD $56.36
- Resistance Level
- QURE $15.18
- IRMD $59.31
- Average True Range (ATR)
- QURE 1.07
- IRMD 1.51
- MACD
- QURE -0.54
- IRMD 0.37
- Stochastic Oscillator
- QURE 29.76
- IRMD 100.00
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.